Sora Care’s Post

17% of people who take medical cannabis in Canada use it to manage IBS symptoms - Medical Cannabis Access Survey. Though a considerable number, human studies are still lacking and have yet to confirm significant effects. "There is no one-size-fits-all approach for managing Irritable Bowel Syndrome since every individual has their own unique experience with symptoms and triggers."- Canadian Digestive Health Foundation This is why medical cannabis is rarely the first choice treatment, its effectiveness varies greatly from one person to another. For some where classic treatments have failed can opt for medical cannabis, with personalized treatment plans and monitoring from a healthcare professional. Contact us for an appointment: https://loom.ly/p0B7owM or call us at 844-223-8886 or link in bio #IBS #Irritableboweldisease #medicalcannabis #cbd #thc #canada #MCAS #Digestion #virtualcare

If it is medicine, it is and should be subsidized

"Medicinal #Cannabis has been approved by the insurer based off an IME report" - NOW WHAT? This is a statement we receive all the time in our referrals. Although approval may have been granted by the insurer, this does not mean the medication itself is going to be effective. Who do you ask whether this medicine is effective? The prescriber? The patient? The NTD? - What about Independent Med Management ? The purpose for the Medicinal Cannabis Management Program (#MCMP) is to establish clear treatment goals prior to commencing a 12 week TRIAL. Our pharmacists will critically evaluate whether these agreed goals have been successful before providing an opinion whether ongoing funding outside of this timeframe is considered reasonable. Want to know more? Send me a message or comment "YES" below.

Czech GPs Will be Able to Prescribe Medical Cannabis Next Year Starting April 1, 2025, general practitioners will be authorized to prescribe cannabis for pain relief, a significant step toward meeting patient demand and reducing dependency on traditional analgesics and opiates. Read more: https://lnkd.in/eBRvp28n #ACS #Cannaspecialists #Cannabis #Medicalcannabis #CzechRepublic #GP

Why Releaf is Leading the Way in Medical Cannabis Care in the UK At Releaf, we are committed to delivering the full patient experience all under one roof, and we are proud to be at the forefront of the UK’s medical cannabis industry. Our approach is simple: we never compromise on patient care. From the moment you connect with us, our dedicated team works to provide personalised guidance and support throughout your treatment journey. What sets Releaf apart is our holistic service. We ensure that each patient’s needs are fully addressed, from consultations with medical professionals to safe, reliable access to high-quality cannabis treatments. All of this is backed by our strict adherence to UK regulations, ensuring a seamless and secure process for every patient. At Releaf, it’s not just about providing a product — it’s about building trust and offering a personalised experience that leads to exceptional results. We're passionate about making a real difference in the lives of those we serve, ensuring that patients can rely on us for support, understanding, and expertise every step of the way. Releaf isn’t just another medical cannabis provider — we’re a partner in your healthcare journey.

At Curaleaf Laboratories, we understand that stepping into the world of medical cannabis can feel like uncharted territory for many healthcare professionals. But with more patients choosing this treatment every day, there’s never been a better time to explore how it could make a difference in your practice. We’re here to make it simple. From understanding the prescribing process to navigating product options, our expert team is ready to guide you every step of the way. How We Can Help: Education & Training: We provide resources to help you feel confident about prescribing. Tailored Support: Whether you’re new to medical cannabis or looking to expand your knowledge, we’ll meet you where you are. Reliable Supply Chain: As the largest medical cannabis manufacturer in the UK, we ensure consistency, quality, and a wide range of dosage forms to meet your patients’ needs. Your patients deserve the best, and we’re committed to helping you offer innovative and safe treatment options. Let’s work together to expand access to medical cannabis and improve patient outcomes. Ready to get started? Reach out today - our team is here to support you.

In the ever-evolving landscape of medical cannabis in the UK, understanding the costs associated with treatment is crucial for patients considering this path. Releaf is at the forefront, offering a transparent breakdown of expenses from consultations to medication prices, and delivery fees. Our innovative Releaf+ subscription service ensures cost-predictability and affordability at just £39.99 per month, covering all necessary aspects of your treatment plan. This approach not only simplifies the process but also provides peace of mind for patients navigating their health journey. Our latest blog post dives deep into the pricing structures, the value of our Releaf+ membership, and how we're working to make medical cannabis accessible to all who need it. With Releaf, patients are not just finding relief; they're finding a community committed to supportive, comprehensive care. We invite you to read our detailed FAQ blog series to understand the real cost of medical cannabis in the UK and discover how Releaf is making a difference. Let's demystify the process together and take the first step towards accessible care. 📝 Read our full blog article here: https://lnkd.in/evf-5HPD

When considering medical cannabis, patients often have numerous questions for their physicians. These questions typically revolve around safety, efficacy, legal issues, and personal concerns. Here are some of the most common questions patients are likely to ask their physicians about medical cannabis. Read more here: https://lnkd.in/ePfQHMCJ #acs #cannabis #medicalcannabis #cannaspecialists #patient #qanda @faq

Happy New Year 2025! 🎉 Florida's medical cannabis sector is experiencing significant growth, with 704 active retail dispensaries and 27 approved Medical Marijuana Treatment Centers (MMTCs). This expansion highlights Florida's commitment to meeting the rising demand for medical cannabis, setting a strong foundation for a promising future in 2025 and beyond. The widespread presence of dispensaries improves accessibility, enabling patients to access essential treatments for various conditions, including pain management, chronic illnesses, and other qualifying ailments. With a focus on enhancing patient care, offering a wide range of products, and enhancing educational resources, the industry is reshaping healthcare and wellness practices, positively impacting individuals throughout the state. Here's to another year of progress, innovation, and transformative advancements in Florida's medical cannabis landscape. Wishing everyone a healthy and prosperous 2025! 🌟 #HappyNewYear2025 #MedicalCannabis #FloridaCannabis #PatientCare #HealthcareInnovation #MMTC #CannabisIndustry #FloridaHealthcare #Wellness #CannabisCommunity #MarijuanaRealEstate #CannabisFacilities #CannabisLandlords #Pioneeringsince2005

If you are a medical cannabis patient, what made you decide to get a prescription and have you found that your medication has had an impact on your reason for seeking treatment? We would love to hear your stories. #lumir #lumirclinic #lumircannabisclinic #cannabiscare #healthandwellness #personcentredcare #patientoutcomes #patientexperience #cannabisresearch #medicinalcannabis #medicalcannabis #cannabismedicine #cannim